Home › NDC Lookup › RxCUI directory › RxCUI 103401

Hydrocortisone 0.025 MG/MG Topical Ointment — RxCUI 103401

RxNorm drug concept · Semantic clinical drug
RxCUI 103401 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI103401
Official nameHydrocortisone 0.025 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydrocortisone 2.5 % Topical Ointment
FDA products mapped11
Package NDCs mapped17
Reported Medicaid activity (SDUD)1,589,189 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used as add-on treatment for ulcerative colitis, especially when it affects the lower or left side of the colon. It is meant to be used along with other supportive measures y...
  • It's usually used once at night. Lie on your left side while you use it and for about 30 minutes after. Try to hold it in at least an hour, ideally all night. Your doctor may sugge...
  • How do I use it, and how long do I keep it in?
  • A usual course is about 21 days, or until you're in remission. Many people feel better within 3 to 5 days. If you use it longer, your doctor will taper you off to every other night...
📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone 0.025 MG/MG Topical Ointment Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrocortisone 0.025 MG/MG Topical Ointment RxCUI 103401

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrocortisone 5492
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrocortisone Topical Ointment 372416
    • Hydrocortisone Topical Product 1164013
    • Topical Ointment 316985
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydrocortisone 0.025 MG/MG 340118

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydrocortisone 0.025 MG/MG SCDC · 340118
  • Hydrocortisone Topical Ointment SCDF · 372416
  • Hydrocortisone Topical Product SCDG · 1164013

📦 FDA Products & Package NDCs

11 products · 17 package NDCs
17 package NDCs map to RxCUI 103401 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00168-0080-16 454 g in 1 JAR (0168-0080-16) Hydrocortisone E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1996-12-16
00168-0080-31 30 g in 1 TUBE (0168-0080-31) Hydrocortisone E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1986-12-16
00168-0146-16 454 g in 1 JAR (0168-0146-16) Hydrocortisone E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1993-05-28
00168-0146-30 29 g in 1 TUBE (0168-0146-30) Hydrocortisone E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1993-05-28
45802-0004-02 1 TUBE in 1 CARTON (45802-004-02) / 20 g in 1 TUBE Hydrocortisone Padagis Israel Pharmaceuticals Ltd 2007-01-31
45802-0004-03 1 TUBE in 1 CARTON (45802-004-03) / 28 g in 1 TUBE Hydrocortisone Padagis Israel Pharmaceuticals Ltd 2006-03-31
45802-0014-02 1 TUBE in 1 CARTON (45802-014-02) / 20 g in 1 TUBE Hydrocortisone Padagis Israel Pharmaceuticals Ltd 2006-06-13
45802-0014-05 454 g in 1 JAR (45802-014-05) Hydrocortisone Padagis Israel Pharmaceuticals Ltd 2006-12-19
50090-0527-00 1 TUBE in 1 CARTON (50090-0527-0) / 20 g in 1 TUBE Hydrocortisone A-S Medication Solutions 2016-06-29
63629-2527-01 454 g in 1 JAR (63629-2527-1) Hydrocortisone Bryant Ranch Prepack 2006-12-19
63629-2528-01 1 TUBE in 1 CARTON (63629-2528-1) / 20 g in 1 TUBE Hydrocortisone Bryant Ranch Prepack 2006-06-13
63629-8817-01 29 g in 1 TUBE (63629-8817-1) Hydrocortisone Bryant Ranch Prepack 2021-09-10
63629-9057-01 1 TUBE in 1 CARTON (63629-9057-1) / 20 g in 1 TUBE Hydrocortisone Bryant Ranch Prepack 2007-01-31
72162-1383-02 1 TUBE in 1 CARTON (72162-1383-2) / 20 g in 1 TUBE Hydrocortisone Bryant Ranch Prepack 2023-09-26
72162-1383-04 1 TUBE in 1 CARTON (72162-1383-4) / 20 g in 1 TUBE Hydrocortisone Bryant Ranch Prepack 2023-09-26
72162-1383-07 454 g in 1 JAR (72162-1383-7) Hydrocortisone Bryant Ranch Prepack 2023-09-26
82804-0084-20 1 TUBE in 1 CARTON (82804-084-20) / 20 g in 1 TUBE Hydrocortisone Proficient Rx LP 2024-03-19
Observed labelers: Bryant Ranch Prepack (7) · E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC (4) · Padagis Israel Pharmaceuticals Ltd (4) · A-S Medication Solutions (1) · Proficient Rx LP (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.